Cite
MLA Citation
Emilie M.J. Brummelen et al.. “Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer.” Oncologist, vol. 26, 2021, pp. 290–e545. http://access.bl.uk/ark:/81055/vdc_100151235712.0x000011